13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q2 2025 · Filed August 12, 2025 · Accession 0001104659-25-076898
Total Value
$662.4M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kymera Therapeutics, Inc. | KYMR | 4,896,462 | $213.7M | 32.26% |
| 2 | Disc Medicine, Inc. | IRON | 2,384,456 | $126.3M | 19.07% |
| 3 | Dyne Therapeutics, Inc. | DYN | 9,130,465 | $86.9M | 13.12% |
| 4 | Sionna Therapeutics, Inc. | SION | 3,694,020 | $64.1M | 9.68% |
| 5 | Third Harmonic Bio, Inc. | 88427A107 | 10,402,286 | $56.5M | 8.53% |
| 6 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $46.4M | 7.01% |
| 7 | Day One Biopharmaceuticals, Inc. | DAWN | 6,430,257 | $41.8M | 6.31% |
| 8 | Korro Bio, Inc. | KRRO | 1,137,149 | $14.2M | 2.14% |
| 9 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $6.7M | 1.02% |
| 10 | Q32 Bio, Inc. | QTTB | 2,092,106 | $3.1M | 0.47% |
| 11 | Generation Bio, Co. | 37148K100 | 8,279,484 | $2.7M | 0.40% |